Factor VIII Inhibitor Bypassing Activity (Feiba) must not be used in the following situations if therapeutic alternatives to Factor VIII Inhibitor Bypassing Activity (Feiba) are available: Hypersensitivity to the product or any of the components.
Disseminated Intravascular Coagulation (DIC).
Acute thrombosis or embolism (including myocardial infarction).
See Precautions.
Other Services
Country
Account